10, 14 Beyond Weight and Sugar: The Protective Effects on the Heart and Kidneys The benefits of GLP-1 therapy are now known to extend well beyond the original targets of blood sugar and weight
Make sure to check with your insurance provider to see what your options are
Sitagliptin is an inhibitor of DPPiv which degrades the active form of GLP1 (Figure 2B), but not total (Mean SD: Vehicle-Control = 17.96 8.81, Olanzapine-Control = 34.90 10.37, Vehicle-Sitagliptin = 21.51 16.27, Olanzapine-Sitagliptin = 24.04 10.72
In rat studies, DSIP administration decreased plasma corticosterone (the rodent equivalent of cortisol) by approximately 30%
If a medication hasn't been examined in trials, there's no rigorous proof of its safety or effectiveness
Are Sermorelin and GHK-Cu safe to use together